Atlas Venture Fund X, L.P. 13D/13G Filings for Dianthus Therapeutics, Inc. (DNTH)

Atlas Venture Fund X, L.P. 13D and 13G filings for Dianthus Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-09-15
4:56 pm
Sale
2023-09-1113DDIANTHUS THERAPEUTICS INC
DNTH
Atlas Venture Fund X, L.P.186,089
1.300%
-2,791,359decrease
(-93.75%)
Filing